CVR 19670694Public limited company (A/S)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)Hesteskoen 3, 2880 BagsværdFounded 1 Nov 1996
ACADIA PHARMACEUTICALS A/S
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about ACADIA PHARMACEUTICALS A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexEmployees
6
CVR, 2005
Result
-471K
DKK, annual report 2025
Equity
-1.6M
DKK, annual report 2025
Acadia Pharmaceuticals Inc.100% of capital and votes
Operating company
Dandex estimate: no recent employees or annual report figures to go onJennifer Jane Rhodessince 2 May 2024
Owners of 5% or more. CVR registers shares in bands, not exact figures.
100% of capital and votessince 25 Mar 1997
CVR records founders at incorporation. It does not record whether they are alive or still involved.
2005, annual: 6 employees, 15 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 |
|---|---|---|---|---|---|---|---|---|---|
| Employees | 12 | 23 | 22 | 22 | 27 | 27 | 29 | 35 | 6 |
| FTE | 7 | 16 | 19 | 20 | 27 | 31 | 29 | 46 | 15 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest 2005, published 18 Jul 2007.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2025, DKK: Gross profit not reported, Result for the year -471K
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2025, DKK: Total assets 14.1K, Equity -1.6M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -21 | -254 | -151 | Not reported | Not reported |
| Result for the year | -21 | -254 | -151 | -99 | -471 |
| Equity | -588 | -841 | -993 | -1,092 | -1,563 |
| Total assets | 6 | 5 | 3 | 55 | 14 |
| Employees (average) | 0 | 0 | 0 | 0 | 0 |
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseDebt conversionPaid in 21,760,500 | None | 21,760,500 | None | 601,000 | |
| IncreaseCashPaid in 18,500,000, cash price 185.00, implied value 111,000,000 | 185.00 | 18,500,000 | 111,000,000 | 600,000 | |
| FoundingNot read from the announcement | None | None | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 20 Nov 2026.
33 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Ny adresse: c/o Pramo ApS, Hesteskoen 3, 2880 Bagsværd
Vedtægter ændret: 02.05.2024
Ny adresse: c/o Pramo ApS, Bagsværd Hovedgade 141, 1. th, 2880 Bagsværd
Ny kommune: Gladsaxe
Bestyrelse:
Fratrådte:
Austin Kim, den 02.05.2024.
Tiltrådte:
Jennifer Jane Rhodes, den 02.05.2024, Peter Francis Chae, den 02.05.2024.
Direktion:
Fratrådte:
Austin Kim, (adm. dir), den 02.05.2024.
Tiltrådte:
Jennifer Jane Rhodes, (adm. dir), den 02.05.2024.
Bestyrelse:
Fratrådte:
Elena Heather Ridloff, den 06.07.2022.
Tiltrådte:
James Kenji Kihara, den 06.07.2022.
Bestyrelse:
Fratrådte:
Eric Miller, (formand), den 18.11.2019, Martin Choy, den 18.11.2019.
Tiltrådte:
Elena Heather Ridloff, den 18.11.2019, Martin Choy, (formand), den 18.11.2019.
Direktion:
Fratrådte:
Todd Young, (adm. dir), den 27.05.2019.
Tiltrådte:
Austin Kim, (adm. dir), den 27.05.2019.
Bestyrelse:
Fratrådte:
Justin Thacker, (formand), den 27.05.2019, Todd Young, den 27.05.2019.
Tiltrådte:
Austin Kim, den 27.05.2019, Eric Miller, (formand), den 27.05.2019.
Direktion:
Fratrådte:
Glenn Frederick Baity (adm. dir), den 31.05.2018.
Tiltrådte:
Todd Young (adm. dir), den 31.05.2018.
Bestyrelse:
Fratrådte:
Glenn Frederick Baity, den 31.05.2018, Justin Thacker, den 31.05.2018, Todd Young (formand), den 31.05.2018.
Tiltrådte:
Justin Thacker (formand), den 31.05.2018, Martin Choy, den 31.05.2018, Todd Young, den 31.05.2018.
Direktion:
Fratrådte:
Uli Alf Hacksell (adm. dir), den 23.05.2017.
Tiltrådte:
Glenn Frederick Baity (adm. dir), den 23.05.2017.
Bestyrelse:
Fratrådte:
Torsten Erik Rasmussen (formand), den 23.05.2017, Uli Alf Hacksell, den 23.05.2017.
Tiltrådte:
Justin Thacker, den 23.05.2017, Todd Young (formand), den 23.05.2017.
Direktion:
Fratrådte:
.
Bestyrelse:
Udtrådt af bestyrelsen:
Thomas Aasen, den 26.05.2014.
Indtrådt i bestyrelsen:
Glenn Frederick Baity, den 26.05.2014.
Ny adresse:
c/o Bruun & Hjejle, Nørregade 21, 1165 København K.
Vedtægter ændret:
31.05.2010.
Ny adresse:
c/o Bruun & Hjejle, Bredgade 38, 1260 København K.
Bestyrelse:
Tiltrådt som formand:
Torsten Erik Rasmussen, den 31.03.2010, Fratrådt som formand, men forbliver i bestyrelsen: Uli Alf Hacksell, den 31.03.2010.
Udtrådt af bestyrelsen:
Bo-Ragnar Tolf, den 31.03.2010.
Indtrådt i bestyrelsen:
Thomas Aasen, den 31.03.2010.
Direktion:
Udtrådt af direktionen:
Bo-Ragnar Tolf, den 31.03.2010.
Indtrådt i direktionen:
Uli Alf Hacksell (adm. dir), den 31.03.2010.
Vedtægter ændret:
27.05.2009.
Revision:
Udtrådt af revisionen:
CVR-NR. 16994294 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, den 27.05.2009.
Revision:
Udtrådt af revisionen:
PricewaterhouseCoopers I/S, den 30.06.2005.
Indtrådt i revisionen:
CVR-NR. 16994294 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB, Strandvejen 44, 2900 Hellerup, den 30.06.2005.
Bestyrelse:
Tiltrådt som formand:
Uli Alf Hacksell, den 08.02.2007.
Udtrådt af bestyrelsen:
Mark Robert Brann, den 08.02.2007.
Indtrådt i bestyrelsen:
Adm. direktør Bo-Ragnar Tolf, den 08.02.2007.
Bestyrelse:
Udtrådt af bestyrelsen:
Martinus Adrianus van Osch, den 29.05.2006.
Indtrådt i bestyrelsen:
Uli Alf Hacksell, den 29.05.2006.
Vedtægter ændret:
07.12.2005.
Ny adresse:
c/o Jonas Bruun, Bredgade 38, 1260 København K.
Ny kommune:
København.
Bestyrelse:
Udtrådt af bestyrelsen:
Arne Gillin, den 08.10.2003, Povl Krogsgaard-Larsen, den 08.10.2003.
Indtrådt i bestyrelsen:
Martinus Adrianus van Osch, den 08.10.2003, Direktør Torsten Erik Rasmussen, den 08.10.2003.
Vedtægter ændret:
28.05.2002.
Vedtægter ændret:
19.12.2001.
Kapitalforhøjelse:
kr. 1.000,00 indbetalt ved konvertering af gæld, kurs 2.176.050,00.
Kapitalen udgør herefter kr. 601.000,00.
Direktion:
Udtrådt af direktionen:
Uli Alf Hacksell, den 01.01.2001.
Indtrådt i direktionen:
Adm. direktør Bo-Ragnar Tolf (adm. dir), den 01.01.2001.
Revision:
Udtrådt af revisionen:
HELLERUP AFDELING.
Indtrådt i revisionen:
PricewaterhouseCoopers, 2900 Hellerup.
Revision:
Udtrådt af revisionen:
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSAKTIESELSKAB.
Indtrådt i revisionen:
HELLERUP AFDELING, 2900 Hellerup.
Direktion:
Udtrådt af direktionen:
Anni Lotte Kirstine Pedersen, den 25.05.1999.
Indtrådt i direktionen:
Uli Alf Hacksell, den 25.05.1999.
Bestyrelse:
Udtrådt af bestyrelsen:
Indtrådt i bestyrelsen:
Professor,dr. pharm Povl Krogsgaard-Larsen.
Direktion:
Udtrådt af direktionen:
Indtrådt i direktionen:
LOTTE SØNDERBJERG PEDERSEN, 1871 Fr.berg C.
Vedtægter ændret:
18.08.1997.
Nyt navn:
ACADIA PHARMACEUTICALS A/S.
Nyt binavn: RECEPTOR TECHNOLOGIES A/S (ACADIA PHARMACEUTICALS A/S).
Ny adresse:
Fabriksparken 58, 2600 Glostrup.
Vedtægter ændret:
04.02.1997.
Nyt navn:
RECEPTOR TECHNOLOGIES A/S.
Ny adresse:
c/o Jonas Bruun Advokatfirma, Bredgade 38, 1260 København K.
Kapitalforhøjelse:
kr. 100.000,00 indbetalt kontant, kurs 18.500,00.
Kapitalen udgør herefter kr. 600.000,00.
Bestyrelse:
Udtrådt af bestyrelsen:
Sebastian Benjamin Bahn Christoffersen, den 04.02.1997, Victor Christoffersen, den 04.02.1997, Helen Mimi Janniche, den 04.02.1997.
Indtrådt i bestyrelsen:
Mark Robert Brann (formand), den 04.02.1997, Direktør Peter Høngård Andersen, den 04.02.1997, Direktør Arne Gillin, den 04.02.1997.
Direktion:
Udtrådt af direktionen:
Victor Christoffersen, den 04.02.1997.
Indtrådt i direktionen:
Direktør Peter Høngård Andersen, den 04.02.1997.
Selskabet tegnes af den samlede bestyrelse, af to medlemmer af bestyrelsen i forening eller af et bestyrelsensmedlem i forening med en direktør.
Revision:
Udtrådt af revisionen:
Nis Jørn Bennetzen, den 04.02.1997.
Indtrådt i revisionen:
REG.NR. A/S212885 PRICE WATERHOUSE/ SEIER-PETERSEN STATSAUTORISERET REVISIONSAKTIESELSKAB, Tuborg Boulevard 1, 2900 Hellerup, den 04.02.1997.
Regnskabsår ændret til:
01.01 - 31.12.
Første regnskabsår:
01.11.1996 - 31.12.1997.
Vedtægter ændret:
11.03.1997.
Ny adresse:
Fabrikaparken 58, 2600 Glostrup.
Ny kommune:
Albertslund.
Stiftelsesdato:
01.11.1996.
Seneste vedtægtsdato:
01.11.1996.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 100,00.
Stifter:
REG.NR. ApS57050 ASX 4050 ApS, c/o adv. Victor Christoffersen, Rosenborggade 3, 1130 København K, den 01.11.1996.
Bestyrelse:
Sebastian Benjamin Bahn Christoffersen, den 01.11.1996, Advokat Victor Christoffersen, den 01.11.1996, Helen Mimi Janniche, den 01.11.1996.
Direktion:
Advokat Victor Christoffersen, den 01.11.1996.
Selskabet tegnes af et medlem af bestyrelsen, en direktør eller den samlede bestyrelse.
Revision:
Statsaut. revisor Nis Jørn Bennetzen, 1414 København K, den 01.11.1996.
Første regnskabsår:
01.11.1996 - 31.03.1998.
Regnskabsår:
01.04 - 31.03.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 20 Nov 2026.
What Pro holds for ACADIA PHARMACEUTICALS A/S:
Have Pro? Sign in.
P-number 1003991659Fabriksparken 58, 2600 Glostrup
P-number 1012439381Hesteskoen 3, 2880 Bagsværd
P-number 1010534395Fruebjergvej 3, 2100 København Ø
P-number 1011010675Smedeland 14, 2600 Glostrup
No other current company drawn.
No other current company drawn.
No other current company drawn.
No other current company drawn.